88282-10-4 Usage
Uses
Used in Pharmaceutical Industry:
1,3-Benzodioxole-5-propanoic acid, b-hydroxy-a-[[(phenylmethoxy)carbonyl] is used as a pharmaceutical candidate due to its diverse functional groups, which may contribute to its effectiveness in treating various medical conditions.
Used in Medicinal Chemistry:
1,3-Benzodioxole-5-propanoicacid,b-hydroxy-a-[[(phenylmethoxy)carbonyl is utilized in medicinal chemistry as a building block for the synthesis of other biologically active molecules, capitalizing on its structural complexity and functional group versatility.
Used in Drug Synthesis:
1,3-Benzodioxole-5-propanoic acid, b-hydroxy-a-[[(phenylmethoxy)carbonyl] is employed in the synthesis of new drugs, leveraging its unique structure to create novel therapeutic agents with potential applications in various medical fields.
Check Digit Verification of cas no
The CAS Registry Mumber 88282-10-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,2,8 and 2 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 88282-10:
(7*8)+(6*8)+(5*2)+(4*8)+(3*2)+(2*1)+(1*0)=154
154 % 10 = 4
So 88282-10-4 is a valid CAS Registry Number.
88282-10-4Relevant articles and documents
Resolution method of droxidopa key intermediates
-
Paragraph 0010; 0019; 0020; 0025, (2019/07/16)
The invention relates to a resolution method of droxidopa threo type key intermediates (key intermediate I, key intermediate II and key intermediate III in synthetic routes 1, 2 and 3), which is characterized in that a non-alkaloid, commercially available
Process for producing 3-(3,4-dihydroxyphenyl) serine
-
, (2008/06/13)
A process for producing racemic or optically active threo- or erythro-3-(3,4-dihydroxyphenyl)serine which comprises phthaloylating the amine group of a racemic or optically active threo- or erythro-3-(3,4-dihydroxyphenyl)serine derivative to yield a racem
Process for producing threo-3-(3,4-dihydroxyphenyl)serine
-
, (2008/06/13)
A process for producing an optically active threo-3-(3,4-dihydroxyphenyl)serine represented by the formula STR1 which is useful as a remedy for peripheral orthostatic hypotension or as an antidepressant, which process comprises treating threo-3-(3,4-methy